519 related articles for article (PubMed ID: 28930026)
1. Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008-2015.
Tanaka T; Oishi T; Miyata I; Wakabayashi S; Kono M; Ono S; Kato A; Fukuda Y; Saito A; Kondo E; Teranishi H; Tanaka Y; Wakabayashi T; Akaike H; Ogita S; Ohno N; Nakano T; Terada K; Ouchi K
Emerg Infect Dis; 2017 Oct; 23(10):1703-1706. PubMed ID: 28930026
[TBL] [Abstract][Full Text] [Related]
2. Prevalence, genotyping and macrolide resistance of Mycoplasma pneumoniae among isolates of patients with respiratory tract infections, Central Slovenia, 2006 to 2014.
Kogoj R; Mrvic T; Praprotnik M; Kese D
Euro Surveill; 2015; 20(37):. PubMed ID: 26536357
[TBL] [Abstract][Full Text] [Related]
3.
Ishiguro N; Sato R; Kikuta H; Nakanishi M; Aoyagi H; Mori T; Nagano N; Tabata Y; Hazama K; Konno M; Yamanaka T; Azuma K; Tanaka H; Narita M; Morita K; Odagawa Y; Ishizaka A; Tsuchida A; Sasaki S; Horino A; Kenri T; Togashi T; Manabe A
J Med Microbiol; 2021 Jun; 70(6):. PubMed ID: 34165424
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistant Mycoplasma pneumoniae pneumonia in paediatric patients.
Kawai Y; Miyashita N; Yamaguchi T; Saitoh A; Kondoh E; Fujimoto H; Teranishi H; Inoue M; Wakabayashi T; Akaike H; Ogita S; Kawasaki K; Terada K; Kishi F; Ouchi K
Respirology; 2012 Feb; 17(2):354-62. PubMed ID: 22077195
[TBL] [Abstract][Full Text] [Related]
5. Regional Differences in Prevalence of Macrolide Resistance among Pediatric Mycoplasma pneumoniae Infections in Hokkaido, Japan.
Ishiguro N; Koseki N; Kaiho M; Kikuta H; Togashi T; Oba K; Morita K; Nagano N; Nakanishi M; Hazama K; Watanabe T; Sasaki S; Horino A; Kenri T; Ariga T;
Jpn J Infect Dis; 2016 May; 69(3):186-90. PubMed ID: 26166502
[TBL] [Abstract][Full Text] [Related]
6. Emergence of Macrolide-Resistant Mycoplasma pneumoniae in Hong Kong Is Linked to Increasing Macrolide Resistance in Multilocus Variable-Number Tandem-Repeat Analysis Type 4-5-7-2.
Ho PL; Law PY; Chan BW; Wong CW; To KK; Chiu SS; Cheng VC; Yam WC
J Clin Microbiol; 2015 Nov; 53(11):3560-4. PubMed ID: 26338857
[TBL] [Abstract][Full Text] [Related]
7. Low Incidence of Macrolide-Resistant Mycoplasma pneumoniae between April 2016 and March 2017 in Akita Prefecture, Japan.
Suzuki S; Konno T; Shibata C; Saito H
Jpn J Infect Dis; 2018 Nov; 71(6):477-478. PubMed ID: 30175736
[No Abstract] [Full Text] [Related]
8. Macrolide resistance of Mycoplasma pneumoniae, South Korea, 2000-2011.
Hong KB; Choi EH; Lee HJ; Lee SY; Cho EY; Choi JH; Kang HM; Lee J; Ahn YM; Kang YH; Lee JH
Emerg Infect Dis; 2013 Aug; 19(8):1281-4. PubMed ID: 23876792
[TBL] [Abstract][Full Text] [Related]
9. Clinical Characteristics of Macrolide-Resistant Mycoplasma pneumoniae from Children in Jeju.
Kim YJ; Shin KS; Lee KH; Kim YR; Choi JH
J Korean Med Sci; 2017 Oct; 32(10):1642-1646. PubMed ID: 28875608
[TBL] [Abstract][Full Text] [Related]
10. Macrolide resistance in Mycoplasma pneumoniae, Israel, 2010.
Averbuch D; Hidalgo-Grass C; Moses AE; Engelhard D; Nir-Paz R
Emerg Infect Dis; 2011 Jun; 17(6):1079-82. PubMed ID: 21749775
[TBL] [Abstract][Full Text] [Related]
11. Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates.
Li X; Atkinson TP; Hagood J; Makris C; Duffy LB; Waites KB
Pediatr Infect Dis J; 2009 Aug; 28(8):693-6. PubMed ID: 19633515
[TBL] [Abstract][Full Text] [Related]
12. Severe community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae in a 6-year-old boy.
Lung DC; Chan YH; Kwong L; Que TL
Hong Kong Med J; 2011 Oct; 17(5):407-9. PubMed ID: 21979480
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of Mycoplasma pneumoniae infection identified on culture in a pediatric clinic.
Katsushima Y; Katsushima F; Suzuki Y; Seto J; Mizuta K; Nishimura H; Matsuzaki Y
Pediatr Int; 2015 Apr; 57(2):247-52. PubMed ID: 25265270
[TBL] [Abstract][Full Text] [Related]
14. Macrolide-resistant Mycoplasma pneumoniae in adults with community-acquired pneumonia.
Miyashita N; Oka M; ; Kawai Y; Yamaguchi T; Ouchi K
Int J Antimicrob Agents; 2010 Oct; 36(4):384-5. PubMed ID: 20674283
[No Abstract] [Full Text] [Related]
15. Epidemiology and mechanism of drug resistance of Mycoplasma pneumoniae in Beijing, China: A multicenter study.
Guo DX; Hu WJ; Wei R; Wang H; Xu BP; Zhou W; Ma SJ; Huang H; Qin XG; Jiang Y; Dong XP; Fu XY; Shi DW; Wang LY; Shen AD; Xin DL
Bosn J Basic Med Sci; 2019 Aug; 19(3):288-296. PubMed ID: 30878034
[TBL] [Abstract][Full Text] [Related]
16. Genetic diversity and macrolide resistance of Mycoplasma pneumoniae isolates from two consecutive epidemics in Slovenia.
Kogoj R; Praprotnik M; Mrvič T; Korva M; Keše D
Eur J Clin Microbiol Infect Dis; 2018 Jan; 37(1):99-107. PubMed ID: 28948376
[TBL] [Abstract][Full Text] [Related]
17. [Survey of macrolide resistance in Mycoplasma pneumoniae in adult patients with community-acquired pneumonia in Beijing, China].
Yin YD; Cao B; Wang H; Wang RT; Liu YM; Gao Y; Qu JX; Han GJ; Liu YN
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Dec; 36(12):954-8. PubMed ID: 24503430
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic sensitivity of 40 Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant isolates from Beijing, China.
Zhao F; Lv M; Tao X; Huang H; Zhang B; Zhang Z; Zhang J
Antimicrob Agents Chemother; 2012 Feb; 56(2):1108-9. PubMed ID: 22106216
[TBL] [Abstract][Full Text] [Related]
19. Characterization of macrolide resistance of Mycoplasma pneumoniae in children in Shenzhen, China.
Ma Z; Zheng Y; Deng J; Ma X; Liu H
Pediatr Pulmonol; 2014 Jul; 49(7):695-700. PubMed ID: 23861188
[TBL] [Abstract][Full Text] [Related]
20. Community outbreak of macrolide-resistant Mycoplasma pneumoniae in Yamagata, Japan in 2009.
Suzuki Y; Itagaki T; Seto J; Kaneko A; Abiko C; Mizuta K; Matsuzaki Y
Pediatr Infect Dis J; 2013 Mar; 32(3):237-40. PubMed ID: 23114374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
